Master the internal auditory canal MRI protocol: sub-millimeter CISS/FIESTA, post-contrast 3D T1 FS, susceptibility artifact fixes, and vestibular schwannoma pitfalls.

7 Critical Internal Auditory Canal MRI Protocol Steps Every Radiographer and Radiologist Must Master in 2026

At a glance: the internal auditory canal MRI protocol

Protocol Snapshot

Core sequences

Sub-millimeter 3D T2 steady-state (CISS/FIESTA) and post-contrast 3D T1 fat-saturated imaging through the internal auditory canals and cerebellopontine angles.

Contrast protocol

10–15 mL (0.1 mmol/kg) GBCA at 2.0 mL/s, followed by a 100 mL saline chaser at 2.0 mL/s.

Artifact reduction

Primary artifact is magnetic susceptibility at the petrous bone. Mitigated with thin slices, high bandwidth, or transition to 3D TSE (SPACE/VISTA).

Top pitfalls

Radiographer: uncorrected susceptibility distortion at the skull base. Radiologist: missed intracanalicular lesion on inadequate-resolution imaging. Physician: ordering a routine brain MRI instead of the dedicated IAC protocol.

Introduction

The internal auditory canal MRI protocol is a highly localized, sub-millimeter examination designed to answer one of the most common referrals in neuro-otology: unilateral or asymmetric sensorineural hearing loss. Within a bony canal only a few millimeters wide, this protocol must resolve the facial nerve, the cochlear and vestibular divisions of the vestibulocochlear nerve, and any small intracanalicular mass, all while contending with the single most severe susceptibility environment anywhere in the head — the dense, air-bone interface of the petrous temporal bone.^[1]

This is Day 5 of this protocol-mastery series, addressing the dedicated Internal Auditory Canals (IACs) protocol. Unlike whole-brain screening protocols, this examination is defined by two highly specialized sequence families working in tandem: a sub-millimeter 3D T2 steady-state acquisition (CISS or FIESTA) that exploits the natural CSF-nerve contrast within the canal to outline the individual cranial nerves without any contrast agent, and a post-contrast 3D T1 fat-saturated sequence that detects the enhancement pattern of a small intracanalicular tumor or inflammatory process that the T2 sequence alone cannot fully characterize.

For facial nerve palsy specifically, this protocol’s ability to trace the entire intracranial and intratemporal course of the facial nerve — from the brainstem origin through the IAC, labyrinthine segment, geniculate ganglion, and beyond — allows radiologists to localize the level of nerve involvement even when the underlying cause (Bell’s palsy, herpes zoster oticus, or a facial nerve schwannoma) cannot be determined with certainty from imaging alone. This localization information is frequently decisive in guiding further work-up and management.

The defining technical tension in this protocol is the magnetic susceptibility artifact at the petrous bone, arising from the abrupt magnetic field inhomogeneity at the interface between dense cortical bone, air-filled mastoid cells, and soft tissue. Because this artifact is most severe with gradient-echo-based steady-state sequences precisely at the skull base — the exact anatomical region this protocol exists to interrogate — technologists and radiologists must understand both how to minimize this distortion prospectively and when to substitute an alternative, less susceptibility-prone sequence entirely.

This article is written for three overlapping audiences who each interact with this protocol differently. Radiographers need a precise, repeatable sub-millimeter acquisition and a clear understanding of when and how to counteract petrous bone susceptibility. Radiologists need a structured framework for detecting and characterizing small intracanalicular lesions against a background of expected anatomical variation and artifact. Otolaryngologists and referring physicians need to understand why a dedicated IAC protocol, rather than a routine brain MRI, is essential for confidently excluding a small vestibular schwannoma in a patient presenting with asymmetric hearing loss.

Few protocols in neuroradiology demand as much precision from as small a target as this one. The IAC measures only a centimeter or so in length, and the nerves within it are millimeters in diameter, yet the clinical stakes of missing a small lesion within this space are substantial: an undetected vestibular schwannoma continues to grow silently, and the difference between a 5 mm and a 15 mm tumor at diagnosis can determine whether hearing preservation and facial nerve function remain realistic surgical goals. This combination of extreme technical demand and high clinical stakes is what makes disciplined protocol execution so consequential here.

The steady-state, non-contrast approach to IAC imaging described throughout this article represents a meaningful technical evolution from earlier protocols that relied solely on thick-slice, contrast-enhanced T1 imaging, which frequently lacked the spatial resolution to detect the smallest intracanalicular lesions or to confidently trace individual nerve fascicles. Understanding why this dual steady-state and post-contrast approach superseded single-sequence protocols equips radiographers and radiologists to recognize when a legacy, lower-resolution protocol is inappropriately still in use at their own institution.

Anatomy: the internal auditory canal and cerebellopontine angle

The internal auditory canal (IAC) is a bony canal within the petrous portion of the temporal bone, extending from the porus acusticus at the cerebellopontine angle (CPA) cistern to the fundus, where it terminates at the lateral end near the inner ear structures. The canal transmits the facial nerve (cranial nerve VII) and the vestibulocochlear nerve (cranial nerve VIII), along with the labyrinthine artery. A thorough working knowledge of this compact anatomy is the foundation on which every subsequent section of this article — from sequence selection to pitfall recognition — is built.

The four-quadrant fundus and Bill’s bar

At the fundus of the IAC, a vertical bony crest called Bill’s bar and a horizontal crest called the crista falciformis divide the canal into four quadrants, each transmitting a specific nerve: the facial nerve occupies the anterosuperior quadrant, the superior vestibular nerve the posterosuperior quadrant, the cochlear nerve the anteroinferior quadrant, and the inferior vestibular nerve the posteroinferior quadrant. This four-quadrant anatomy is a critical surgical landmark, particularly for facial-nerve-sparing resection of vestibular schwannoma, and confident sub-millimeter depiction of this anatomy is one of the principal justifications for the steady-state sequence at the core of this protocol. Surgeons planning a hearing-preservation approach rely directly on the radiologist’s description of tumor relationship to these quadrants when counseling patients on the likelihood of successful cochlear nerve preservation.

Cerebellopontine angle cistern

The CPA cistern is a CSF-filled space between the cerebellum, pons, and petrous temporal bone at the porus acusticus, forming the medial extent of the IAC. Most vestibular schwannomas arise within the IAC itself and grow medially into this cistern, producing the classic “ice-cream cone” configuration — the ice-cream representing the extrameatal cisternal component and the cone representing the intracanalicular component that expands the porus acusticus. The relative proportion of intracanalicular versus cisternal tumor volume is a key descriptor in surgical planning discussions, since a tumor that is predominantly cisternal with only minimal canalicular extension behaves differently, both in growth pattern and in surgical accessibility, than one that is predominantly intracanalicular.

Facial nerve course

Beyond the IAC, the facial nerve continues through the labyrinthine segment (the narrowest and most susceptibility-prone segment of its entire course), the geniculate ganglion, the tympanic segment, and the mastoid segment before exiting the skull base at the stylomastoid foramen. Enhancement of the geniculate ganglion is a recognized normal variant that must be distinguished from pathological perineural spread or facial nerve schwannoma. Tracing the entire course of the nerve on sequential post-contrast images, rather than reviewing only the IAC segment in isolation, is essential whenever facial nerve pathology is a specific clinical concern, since perineural tumor spread and inflammatory processes frequently extend beyond the canal itself.

Inner ear structures

At the fundus of the IAC, the vestibulocochlear nerve fibers terminate in the cochlea, vestibule, and semicircular canals — collectively the membranous labyrinth, filled with CSF-like endolymph and perilymph that produce the bright fluid signal exploited by the steady-state sequence to outline the labyrinthine architecture in exquisite detail without any contrast administration. Careful review of labyrinthine fluid signal on every study, even when the primary clinical question relates to a possible mass lesion, allows incidental detection of labyrinthine ossification or fibrosis that carries direct relevance to future cochlear implant candidacy.

Petrous apex and skull base relationships

The petrous temporal bone forms one of the densest bony structures in the body and is directly adjacent to air-filled mastoid air cells, producing the severe local magnetic field inhomogeneity responsible for this protocol’s primary named artifact. Petrous apex asymmetry, including asymmetric marrow fat versus fluid signal, is a frequent incidental finding that must be distinguished from a true petrous apex lesion such as cholesterol granuloma or cholesteatoma. A useful practical rule is that asymmetric petrous apex fluid or fat signal without an associated mass, expansion, or enhancement is almost always a benign, non-pneumatized marrow variant rather than a lesion requiring further work-up.

Cranial nerve VII versus VIII differentiation

Confidently distinguishing the facial nerve from the vestibulocochlear nerve within the crowded confines of the IAC is essential whenever a mass appears to arise from one nerve rather than the other, since a facial nerve schwannoma requires a fundamentally different surgical approach than a vestibular schwannoma of identical size. On the sub-millimeter steady-state sequence, the facial nerve is typically thinner and positioned anterosuperiorly, while the larger vestibulocochlear nerve complex occupies the remaining three quadrants — a relationship best appreciated on true axial images through the mid-canal and cross-referenced against the four-quadrant fundus anatomy described above. When a mass appears to displace rather than arise from the facial nerve, this favors a vestibular origin, while circumferential thickening or tubular expansion centered on the expected facial nerve course favors a primary facial nerve process.

Vascular loop variants

The anterior inferior cerebellar artery (AICA) frequently loops into or near the porus acusticus and occasionally extends partially into the IAC itself as a normal anatomical variant. This vascular loop can produce a flow void that must be distinguished from a small solid lesion, and its presence and degree of intracanalicular extension is also clinically relevant in the rare context of suspected vascular compression syndromes affecting the seventh or eighth cranial nerve. Reporting the presence and laterality of a prominent vascular loop, even when asymptomatic, provides useful baseline information should the patient later develop symptoms suggestive of neurovascular conflict such as hemifacial spasm or disabling positional vertigo.

MR tissue relaxation values

Understanding the relative T1 and T2 relaxation behavior of the structures within and around the IAC underpins the entire steady-state imaging strategy used in this protocol, which depends on maximizing the inherent contrast between CSF/endolymph and adjacent nerve tissue rather than on any contrast agent.

Approximate T1 and T2 relaxation characteristics relevant to the IAC protocol at 1.5T and 3T

Tissue	T1 behavior	T2 behavior	Relevance to CISS/FIESTA contrast
CSF (CPA cistern, IAC)	Hypointense	Markedly hyperintense	Provides the bright background against which nerves appear as dark filling defects
Endolymph/perilymph (labyrinth)	Hypointense	Markedly hyperintense	Outlines cochlear and vestibular architecture without contrast
Cranial nerves VII/VIII	Isointense to brain	Hypointense relative to CSF	Appear as linear dark filling defects within the bright CSF/endolymph background
Vestibular schwannoma	Isointense to hypointense pre-contrast	Isointense to hyperintense, heterogeneous if cystic	Disrupts the normal nerve-CSF contrast pattern; enhances avidly post-contrast
Petrous bone marrow fat	Hyperintense	Intermediate	Requires fat saturation on post-contrast T1 to avoid obscuring enhancement
Cortical bone (petrous)	Signal void	Signal void	Source of the severe local susceptibility gradient central to this protocol’s primary artifact

The steady-state sequence at the heart of this protocol exploits an unusually favorable contrast mechanism: because CSF and endolymph both have very long T2 relaxation times, they remain bright even at the very short echo times used in balanced steady-state free precession imaging, while the nerves themselves remain relatively dark, producing the high-contrast “MR myelography-like” appearance that allows individual nerve fascicles to be traced without gadolinium.

This same physical mechanism explains why the steady-state sequence is so sensitive to the petrous bone susceptibility artifact discussed throughout this article. Balanced steady-state free precession sequences derive their contrast from a delicate equilibrium between the T2 and T1 relaxation behavior of tissue, and this equilibrium is disrupted by even modest local field inhomogeneity, producing the characteristic banding and signal dropout most pronounced precisely at bone-air interfaces such as the petrous apex and mastoid air cells. Understanding this tradeoff — exceptional intrinsic soft-tissue contrast purchased at the cost of susceptibility sensitivity — is essential context for the artifact-mitigation strategies detailed in the pitfalls and artefact-reduction sections later in this article.

Scanning technique: 10-step protocol

The following ten-step sequence represents the standard workflow for this protocol at most institutions, moving from broad anatomical screening through the dedicated sub-millimeter steady-state acquisition to contrast-enhanced characterization. Each step builds on the last, and the rationale for this specific ordering is discussed in detail following the step list.

1. Patient screening and preparation. Confirm MRI safety screening, renal function status if GBCA is planned, and obtain informed consent. Explain that the examination includes a longer, high-resolution non-contrast sequence followed by a contrast-enhanced series.
2. Coil selection and positioning. Use a dedicated multichannel head coil; position the patient supine with the head immobilized, using a symmetric, level head position to allow accurate side-to-side comparison.
3. Localizer/scout acquisition. Acquire a triplanar localizer centered on the posterior fossa and temporal bones to plan the small-FOV, high-resolution series.
4. Axial FLAIR or T2 TSE of the whole brain. A brief whole-brain series to exclude a coexisting intracranial abnormality and to provide anatomical context for the dedicated IAC series that follows.
5. Sub-millimeter 3D T2 steady-state (CISS/FIESTA). The core diagnostic sequence of this protocol — thin, overlapping sub-millimeter sections through the IACs and CPA cisterns bilaterally, reviewed in axial plane with coronal reformats.
6. High-bandwidth optimization. Confirm receiver bandwidth is set to a high value appropriate for the field strength to minimize the chemical shift and susceptibility distortion inherent to the steady-state sequence at the petrous bone interface.
7. Contrast administration. Deliver the GBCA bolus using a power injector as detailed in the contrast protocol section below.
8. Post-contrast 3D T1 fat-saturated sequence. A thin-slice, fat-saturated T1 acquisition through the IACs and CPA, matched in geometry to the steady-state series to allow direct side-by-side comparison of any candidate lesion.
9. Whole-brain post-contrast T1. A standard whole-brain post-contrast series to assess for any additional intracranial enhancing pathology beyond the immediate temporal bone region.
10. Quality assurance review. Review all series on the console for susceptibility distortion at the petrous apex, adequate bilateral symmetric coverage, and confirm the steady-state and post-contrast series share consistent geometry before releasing the patient.

Scanner comparison: 1.5T vs 3.0T for the internal auditory canal protocol

Parameter	1.5T	3.0T
SNR at sub-millimeter resolution	Baseline — often limiting at true sub-millimeter voxel sizes	~2× higher, better supporting true sub-millimeter isotropic imaging
Magnetic susceptibility at petrous bone	Lower — steady-state sequences generally well tolerated	Markedly higher — often requires transition to 3D TSE (SPACE/VISTA) in problem cases
Chemical shift artifact	Lower	Doubled relative to 1.5T; requires higher receiver bandwidth
Steady-state sequence robustness	Generally reliable, fewer banding artifacts	More prone to banding/dielectric artifact, particularly at the skull base
Typical CISS/FIESTA acquisition time	~4–6 min	~3–5 min with parallel imaging

In practice, both field strengths are widely used for this protocol, but departments running a high volume of 3T IAC studies should have a low threshold for switching from the classic gradient-echo steady-state sequence to a 3D turbo-spin-echo alternative (SPACE or VISTA) whenever susceptibility distortion at the petrous apex threatens to obscure the fundus of the IAC — precisely the region where the smallest, most clinically urgent intracanalicular lesions are located. Departments that maintain both sequence options as pre-built, readily selectable protocol cards, rather than needing to construct the TSE alternative from scratch mid-examination, are better positioned to make this switch efficiently when the situation calls for it.

Why each step earns its place

The initial whole-brain FLAIR series (step 4) provides essential anatomical context and screens for a coexisting intracranial abnormality that could otherwise be missed by a protocol narrowly focused on the temporal bones. The steady-state sequence (step 5) is the diagnostic core of the entire protocol, exploiting the CSF-nerve contrast mechanism described in the relaxation values section above to depict the cranial nerves without any contrast agent. The high-bandwidth optimization (step 6) is not a separate acquisition but a deliberate parameter choice woven into the steady-state sequence design, directly targeting this protocol’s primary named artifact. The post-contrast series (steps 7 through 9) then provides the complementary enhancement information that the non-contrast steady-state sequence cannot supply, completing the two-pillar diagnostic strategy that defines this protocol. Omitting any one of these components — whether the whole-brain context, the steady-state core, or the post-contrast confirmation — meaningfully weakens the overall diagnostic yield of the examination.

Pediatric considerations

IAC and CPA imaging in children is most commonly performed for congenital sensorineural hearing loss work-up, including evaluation for cochlear nerve deficiency or aplasia ahead of cochlear implant candidacy assessment, and less commonly for suspected neurofibromatosis type 2, in which bilateral vestibular schwannomas are pathognomonic. Because the steady-state sequence’s diagnostic value depends entirely on motion-free, sub-millimeter acquisition, young children frequently require sedation to achieve diagnostic image quality, and departments should apply the same immobilization and comfort strategies described elsewhere in this series, with coordinated anesthesia support where sedation is required. Confirming cochlear nerve presence and caliber in the anteroinferior quadrant of the IAC is a specific, high-value task in this pediatric population, since nerve absence or hypoplasia is a critical determinant of expected benefit from cochlear implantation.

Departmental quality assurance and protocol audit

Because this protocol depends on both sub-millimeter spatial fidelity and successful susceptibility artifact management, departments benefit from periodic audit of completed studies against the ten-step checklist above. Common audit findings include inadequate slice thickness selected to save scan time, receiver bandwidth left at a default rather than protocol-specific high setting, and inconsistent geometry between the steady-state and post-contrast series that prevents direct lesion correlation. Structured audit and feedback produces measurably more consistent protocol adherence over time than informal spot-checking alone.

Why MRI, not CT, is the primary modality

While high-resolution CT of the temporal bone provides excellent depiction of bony anatomy, ossicular structures, and can reliably confirm findings such as superior semicircular canal dehiscence, it offers markedly inferior soft-tissue contrast for distinguishing normal nerve tissue from a small intracanalicular tumor, and involves ionizing radiation that is best avoided for the serial surveillance imaging this protocol frequently supports. CT retains a complementary, secondary role in this clinical pathway primarily for bony detail — cochlear implant candidacy assessment, otosclerosis evaluation, and confirmation of suspected semicircular canal dehiscence — but does not substitute for the dedicated MRI protocol described throughout this article for primary soft-tissue diagnosis of vestibular schwannoma and related pathology. The two modalities are best regarded as complementary rather than competing, each answering a distinct component of the overall diagnostic question.

Contrast media protocol

Gadolinium-based contrast agent (GBCA) administration in this protocol serves a complementary rather than primary diagnostic role: the non-contrast steady-state sequence already provides excellent anatomical delineation of the cranial nerves, and the post-contrast series is principally used to confirm and characterize enhancement of any candidate lesion identified on the steady-state images, and to detect small lesions whose signal characteristics on the steady-state sequence alone are ambiguous.

Injection protocol — Internal Auditory Canal (IAC) study

Parameter	Value
GBCA volume	10–15 mL (0.1 mmol/kg)
Flow rate	2.0 mL/s
Saline chaser	100 mL at 2.0 mL/s
Post-injection delay	Standard — no specific delayed phase required for this protocol
Access	Peripheral IV, 20–22G, power-injectable

Why fat saturation is essential on post-contrast imaging

The petrous bone marrow and surrounding skull-base fat produce naturally bright T1 signal that can closely mimic or obscure genuine gadolinium enhancement of a small intracanalicular lesion or the facial nerve. Fat saturation on the post-contrast 3D T1 series is therefore not an optional refinement but an essential component of this protocol, and its omission is a well-recognized cause of both false-positive and false-negative interpretation at the skull base. Spectral fat saturation can itself fail at the curved, air-adjacent geometry of the temporal bone, and departments experiencing persistent fat-suppression failure at this specific location should consider a Dixon-based water-fat separation technique as a more robust alternative, since Dixon methods are inherently less sensitive to the local field inhomogeneity that defeats conventional spectral fat saturation in this anatomical region.

Repeat imaging for surveillance

Patients with a known, small vestibular schwannoma under active observation typically undergo serial MRI at six- to twelve-month intervals to assess for growth, since a meaningful proportion of small vestibular schwannomas remain stable or grow very slowly over years. Because volumetric growth comparison depends on consistent slice geometry and positioning across visits, technologists should reference the prior study’s slice prescription where available rather than planning each surveillance study independently.

Managing adverse reactions

Acute GBCA reactions are rare but require an institutional protocol with immediately available emergency medication and equipment. Mild reactions are managed conservatively with observation; moderate to severe reactions require immediate clinical intervention per institutional anaphylaxis protocols. Because this protocol’s contrast administration occurs partway through a relatively long examination, technologists should remain attentive to the patient throughout the subsequent post-contrast acquisition rather than assuming the early observation period alone is sufficient.

Specific absorption rate (SAR)

Balanced steady-state free precession sequences such as CISS and FIESTA use frequent, closely spaced RF pulses to maintain the steady-state condition that produces their characteristic contrast, making them meaningfully SAR-intensive despite their relatively short overall scan time, particularly at 3T. Understanding this relationship is important because the temptation to increase flip angle for marginally better CSF-nerve contrast carries a disproportionate SAR cost that is easy to underestimate.

SAR reference limits (IEC/ICRP-aligned normal operating mode)

Exposure metric	Normal mode limit
Whole-body average SAR	2 W/kg
Partial-body (head) average SAR	3.2 W/kg
Local SAR (any 10 g tissue)	10 W/kg (head)

Five dose-reduction strategies

1. Reduce flip angle modestly on the steady-state sequence where diagnostic CSF-nerve contrast permits, since SAR scales with the square of flip angle.
2. Increase TR slightly where temporal or spatial resolution requirements allow, providing greater RF energy dissipation between excitations.
3. Use parallel imaging acceleration to reduce both SAR and scan time on the sub-millimeter steady-state series.
4. Limit redundant repeat acquisitions — since steady-state sequences are prone to banding artifact, technologists should first confirm shimming quality rather than reflexively repeating the full sequence, which compounds cumulative SAR unnecessarily.
5. Switch to first-level controlled operating mode only when clinically justified and monitored, per manufacturer and institutional protocol.

These strategies are aligned with guidance from the European Commission Radiation Protection 185 series, the American Association of Physicists in Medicine (AAPM), and the International Commission on Radiological Protection (ICRP) frameworks for non-ionizing RF exposure management in clinical MRI.^[3] In practice, the first and third strategies — modest flip angle reduction combined with parallel imaging acceleration — together typically provide the greatest SAR saving for the least diagnostic tradeoff on the steady-state sequence used in this protocol, and should generally be attempted before resorting to a fundamentally different pulse sequence.

In practice, steady-state sequences deposit RF energy more continuously than pulsed spin-echo sequences of comparable duration, since the balanced steady-state condition requires closely spaced excitation pulses throughout the entire acquisition rather than the more intermittent pulsing pattern of conventional turbo-spin-echo imaging. Departments running this protocol at 3T should confirm the console-reported SAR for the steady-state sequence specifically, rather than assuming a short overall acquisition time guarantees low cumulative RF exposure.

Resource and scheduling implications for hospital administrators

This dedicated protocol typically requires 25 to 35 minutes of table time given the whole-brain screening series, the sub-millimeter steady-state acquisition, and the post-contrast series. Administrators scheduling otolaryngology-referred IAC studies should budget accordingly, since a compressed slot is a well-recognized driver of the inadequate slice thickness and omitted quality checks discussed throughout the pitfalls sections of this article. Departments processing a high volume of asymmetric hearing loss referrals may also benefit from a dedicated, pre-built order set that automatically routes to this protocol rather than a generic brain MRI order, reducing the protocolling-stage ambiguity that otherwise contributes to the clinical pitfalls described later in this article.

Because susceptibility artifact management may require an in-line decision to substitute a 3D TSE sequence for the standard steady-state acquisition, technologists should have this alternative sequence readily available on the console rather than needing to locate or build it during the examination, which can otherwise meaningfully extend table time and disrupt scheduling for subsequent patients.

Quality control and phantom testing

Because this protocol’s diagnostic performance depends on parameters that are individually easy to silently drift out of specification during routine software updates or protocol-card copying between scanners, departments should include this protocol in routine phantom-based quality control alongside standard ACR accreditation testing. Verifying achieved sub-millimeter resolution and confirming that receiver bandwidth has not been inadvertently reduced during a protocol transfer between scanner platforms are both low-cost checks that directly protect against this protocol’s primary named artifact.

Top 10 pathologies detected on this protocol

The following ten conditions represent the majority of the diagnostic workload generated by a dedicated IAC and CPA protocol, spanning the full spectrum from millimeter-scale intracanalicular tumors to inflammatory and congenital conditions of the labyrinth. Each card summarizes characteristic T1/T2 behavior and how this protocol’s technical design supports its detection, while the differential discussion following the card grid addresses the specific look-alike conditions that most commonly complicate interpretation in clinical practice.

Pre-surgical planning considerations

Beyond diagnosis, this protocol frequently informs the choice of surgical approach for confirmed vestibular schwannoma. A retrosigmoid approach is favored for tumors with meaningful cisternal extension regardless of hearing status, a translabyrinthine approach is typically reserved for patients with non-serviceable hearing given its sacrifice of residual cochlear function, and a middle fossa approach is generally limited to small, predominantly intracanalicular tumors in patients with good pre-operative hearing where hearing preservation is the primary goal. Each of these decisions depends directly on the precise localization and extent information that the steady-state and post-contrast sequences in this protocol together provide, reinforcing why technical excellence at the acquisition stage has direct downstream surgical consequences.

Post-treatment imaging surveillance differences

Post-surgical and post-radiosurgery IAC imaging requires several interpretive adaptations beyond the standard technique described in the scanning section above. Following microsurgical resection via a retrosigmoid, translabyrinthine, or middle fossa approach, expected postoperative changes include fat packing of the surgical defect, dural enhancement along the approach corridor, and altered CSF signal that can persist for months and should not be mistaken for residual tumor without the operative note for correlation. Following stereotactic radiosurgery, treated tumors frequently show a transient increase in size and central loss of enhancement in the first 6 to 18 months post-treatment — a pattern reflecting treatment response rather than failure, and one that can cause significant confusion if the radiosurgery date is not explicitly considered during interpretation.

For patients under long-term surveillance after treatment, the same steady-state and post-contrast sequence pairing used for initial diagnosis remains the appropriate technique, with close attention paid to comparing each new study against the immediate post-treatment baseline rather than only the most recent prior study, since gradual changes across many studies can be easy to overlook when only consecutive pairs are compared.

Differential diagnosis considerations

Because the IAC and CPA harbor a relatively narrow set of possible pathologies within a small, crowded anatomical space, distribution and morphology are frequently the deciding factors in reaching a confident diagnosis, as illustrated in the pairwise comparisons below. Signal intensity alone is rarely sufficient given the substantial overlap between several of these entities on conventional sequences.

Vestibular schwannoma versus meningioma. A vestibular schwannoma is centered on and expands the IAC itself, producing the classic ice-cream cone configuration, while a meningioma is dura-based, often has a broader dural attachment with a dural tail, and does not necessarily expand the porus acusticus. Meningiomas may also show characteristic calcification and a more eccentric relationship to the porus, whereas schwannomas are almost invariably centered symmetrically on the canal itself, a distinction that remains useful even in cases where enhancement pattern alone is ambiguous.

Epidermoid cyst versus arachnoid cyst. Both appear CSF-like on conventional T1/T2 imaging, but epidermoid cysts show characteristic restricted diffusion on DWI, while arachnoid cysts follow CSF signal and diffusion characteristics precisely on every sequence. This distinction has direct surgical relevance, since epidermoid cysts require meticulous capsule resection to avoid recurrence, while arachnoid cysts are frequently managed conservatively unless symptomatic mass effect is present.

Vestibular schwannoma versus lipoma. Lipoma follows fat signal on every sequence, including suppression with fat saturation, and does not enhance, while schwannoma enhances avidly and does not suppress with fat saturation. Recognizing a lipoma prospectively avoids not only unnecessary biopsy but also inappropriate surgical planning, since lipomas are typically managed conservatively with observation given their benign, slow-growing nature and the disproportionate surgical risk of attempting resection near critical cranial nerves.

Labyrinthitis versus normal post-operative or post-traumatic change. Diffuse, symmetric labyrinthine enhancement in the correct clinical context (sudden sensorineural hearing loss, recent viral illness) favors labyrinthitis, whereas a history of prior otologic surgery or trauma should prompt caution before attributing enhancement to primary inflammatory disease. Reviewing prior imaging and the surgical history together with the current study is essential before committing to a diagnosis of primary labyrinthitis in any patient with a complex otologic history.

Symptom laterality as a diagnostic anchor

Because this protocol is almost always requested for a unilateral or asymmetric symptom — hearing loss, tinnitus, or facial weakness on one side — the reported laterality of symptoms should always be checked against the side of any identified abnormality before finalizing a report. A candidate lesion identified contralateral to the symptomatic side warrants particular scrutiny, since this discordance may indicate either an incidental, clinically silent finding on the asymptomatic side or, less commonly, a technical labeling error that should be resolved before the report is finalized. This simple cross-check takes only moments but provides a meaningful additional safeguard against reporting errors in a protocol where left-right confusion carries direct surgical planning consequences.

Grading and staging frameworks

The Koos grading system classifies vestibular schwannoma on a four-tier scale based on extrameatal extension and brainstem contact: Grade I is purely intracanalicular, Grade II shows extension into the CPA cistern without brainstem contact, Grade III shows brainstem contact without displacement, and Grade IV shows brainstem displacement or compression. This grading directly informs the choice between observation, stereotactic radiosurgery, and microsurgical resection, and depends entirely on the accurate multiplanar depiction of tumor extent that this protocol’s steady-state and post-contrast sequences together provide.^[6]

For lesions under active surveillance, growth is typically defined as an increase in maximum cisternal diameter of 2 mm or more, or a defined volumetric increase, between successive studies — a threshold that underscores why the consistent, reproducible slice geometry emphasized throughout this article is not a cosmetic preference but a direct determinant of whether true growth can be reliably distinguished from measurement variability.

Pitfalls — radiographers

The primary scanning pitfall identified for this protocol is magnetic susceptibility artifact at the petrous bone, which arises from the abrupt field inhomogeneity at the dense bone-air interface and can distort or obscure the fundus of the IAC on gradient-echo-based steady-state sequences, precisely the region where the smallest clinically significant lesions occur. Unlike patient-dependent artifacts such as motion, this artifact is largely a function of local anatomy and pulse sequence physics, meaning it is present to some degree in nearly every study and its severity is directly controllable through the parameter choices detailed throughout this section.

Radiographer scanning pitfalls

Category	Description	Mitigation
Magnetic susceptibility artifact at the petrous bone (primary)	Field inhomogeneity at the bone-air interface distorts signal at the IAC fundus, mimicking or obscuring pathology	Use thin slices, high receiver bandwidth, or transition from GRE steady-state to 3D TSE (SPACE/VISTA)
Inadequate slice thickness	Slices thicker than sub-millimeter specification cause partial volume averaging that obscures small nerve detail	Confirm true sub-millimeter slice thickness on the steady-state sequence before scanning
Asymmetric positioning	A tilted or rotated head position prevents accurate side-to-side comparison of the two IACs	Use symmetric, level positioning referenced to a fixed anatomical landmark
Omitted fat saturation on post-contrast T1	Bright petrous marrow fat obscures adjacent genuine enhancement	Apply fat saturation routinely on the post-contrast series
Geometry mismatch between steady-state and post-contrast series	Inconsistent slice prescription prevents direct correlation of a candidate lesion between sequences	Match slice geometry between the steady-state and post-contrast series

Susceptibility artifact severity at the petrous bone scales with field strength, echo time, and the intrinsic sensitivity of the pulse sequence to local field inhomogeneity. Gradient-echo-based steady-state sequences such as CISS and FIESTA are inherently more susceptibility-sensitive than spin-echo-based sequences, because they lack the 180-degree refocusing pulse that spin-echo techniques use to compensate for static field inhomogeneity. This is precisely why the targeted remedy for this protocol includes the option to substitute a 3D turbo-spin-echo sequence (SPACE or VISTA) when susceptibility distortion threatens diagnostic quality — the refocusing pulse inherent to TSE-based sequences provides substantially better immunity to this specific artifact, at some cost to the pure CSF-nerve contrast that makes the steady-state sequence the first-choice technique in most cases.

A frequently overlooked contributor to susceptibility artifact severity is inadequate localized shimming: many scanners default to a global, whole-head shim rather than a volume shim localized specifically to the posterior fossa and temporal bones. Technologists should confirm a local shim volume is applied over the region of interest before finalizing the steady-state acquisition, since this single adjustment often meaningfully reduces artifact severity without requiring any change to bandwidth or slice thickness.

Pitfalls — radiologists

The primary interpretation pitfall for this protocol is missing a small intracanalicular lesion on inadequate-resolution imaging, particularly when susceptibility distortion or partial volume averaging at the fundus obscures a lesion measuring only 1 to 2 mm. This pitfall is especially consequential because it is largely silent — an inadequately resolved study can appear entirely unremarkable to a radiologist unaware that image quality at the specific location of interest has been compromised.

Radiologist interpretation pitfalls

Pitfall	Mechanism	Consequence	Mitigation
Missed intracanalicular lesion (primary)	Susceptibility distortion or inadequate slice thickness obscures a small lesion at the fundus	False-negative study in a patient with genuine asymmetric hearing loss	Review both steady-state and post-contrast series together, and request a repeat with TSE substitution if susceptibility distortion is significant
Mistaking susceptibility artifact for pathology	Signal distortion at the petrous apex mimics a filling defect or mass	False-positive finding, unnecessary follow-up imaging	Confirm any suspected lesion is present and consistent across multiple contiguous slices and both steady-state and post-contrast sequences
Overlooking geniculate ganglion enhancement as pathological	Mild, symmetric geniculate ganglion enhancement is a normal variant	Unnecessary work-up for facial nerve pathology	Compare enhancement pattern and symmetry against the contralateral side before reporting a definite abnormality
Failing to differentiate schwannoma from meningioma	Overlapping enhancement pattern between the two most common CPA masses	Inaccurate pre-surgical counseling regarding tumor origin	Assess dural tail, canal expansion pattern, and centering relative to the porus acusticus systematically on every mass

The consequences of a missed small vestibular schwannoma extend directly into patient management: because growth rate and facial-nerve-sparing surgical planning both depend on accurate baseline size measurement, a missed or underestimated lesion on the initial study can lead to an inappropriately delayed diagnosis and a larger, more surgically complex tumor by the time it is eventually detected.

Radiologists new to temporal bone reporting are particularly prone to under-weighting subtle asymmetry between the two IACs — a fundus that appears marginally more filled or a nerve complex that appears marginally thicker on one side than the other. Because normal anatomical variation between the two ears is common, a low threshold for recommending short-interval follow-up imaging in genuinely equivocal cases is preferable to either over-calling a definite abnormality or dismissing a subtle but real asymmetry outright.

Pitfalls — non-radiology physicians

Referring physicians — most commonly otolaryngologists, audiologists, and primary care providers evaluating asymmetric hearing loss — play a decisive role in ensuring the correct protocol is selected from the outset, since the distinction between a routine brain MRI and this dedicated examination is not always obvious to clinicians outside radiology.

Clinical pitfalls for referring, non-radiology physicians

Pitfall	What they see	What it actually is	Clinical danger	What to do
Ordering a routine brain MRI instead of the dedicated IAC protocol (primary)	A standard whole-brain MRI request for suspected asymmetric hearing loss	Routine brain protocols use thicker slices and lack the sub-millimeter steady-state sequence required to detect small intracanalicular lesions	Non-diagnostic study for the specific clinical question, need to repeat with the correct dedicated protocol	Specify “dedicated IAC/CPA MRI” or “internal auditory canal protocol” on the request when asymmetric sensorineural hearing loss is the indication
Treating a negative routine brain MRI as excluding vestibular schwannoma	A report stating “no mass identified” on a non-dedicated study	A routine brain protocol may lack the resolution to exclude a small intracanalicular lesion	False reassurance, delayed diagnosis of a growing tumor	Confirm the dedicated IAC protocol, not a routine brain MRI, was used before excluding vestibular schwannoma
Overlooking audiometric correlation	An imaging report describing a small, stable lesion	Growth rate and clinical hearing status, not imaging appearance alone, drive management decisions between observation, radiosurgery, and resection	Inappropriate treatment selection without full clinical context	Always interpret imaging findings alongside serial audiometry and symptom trajectory

Clear, indication-specific requesting is the single most effective lever a referring physician has over the diagnostic quality of this protocol. A request that simply states “MRI brain, rule out tumor” without specifying the audiometric asymmetry risks being protocolled as a routine screening study, missing the sub-millimeter steady-state sequence that this specific clinical question requires.

Multidisciplinary discussion between otolaryngology, audiology, and radiology is particularly valuable when a small, stable vestibular schwannoma is identified, since the decision between continued observation, radiosurgery, and microsurgical resection depends on factors — patient age, hearing status, tumor growth trajectory, and patient preference — that extend well beyond what imaging alone can determine. A radiology report that documents precise, reproducible measurements using a consistent methodology across serial studies gives this multidisciplinary discussion the most reliable foundation possible.

Pitfall comparison summary

As with other protocols in this series, the three pitfall categories below form a connected error chain rather than three isolated risks. Uncorrected susceptibility distortion at the scanning stage directly increases the risk of both false-positive and false-negative interpretation, which in turn shapes whether a referring physician correctly excludes or pursues further work-up for vestibular schwannoma. Departmental quality-improvement efforts are most effective when they trace a specific adverse outcome back through this full chain rather than attributing the error to a single stage in isolation.

Structured reporting as a mitigation layer

A structured IAC report template that mandates explicit documentation of Koos grade for any identified mass, an explicit statement of image quality with respect to susceptibility artifact at the fundus, and explicit side-to-side comparison of nerve caliber closes many of the gaps identified across all three pitfall tiers simultaneously. This is particularly valuable for surveillance patients, where consistent, structured measurement methodology across successive reports is what ultimately allows true growth to be distinguished from measurement noise. Free-text narrative reporting, by contrast, allows these technical caveats to be omitted or buried, increasing the risk that a referring physician over-anchors on a report that does not clearly flag its own limitations at the fundus.

AI & automation

Deep-learning tools are increasingly applied to temporal bone and CPA imaging, particularly for automated segmentation and volumetric measurement of vestibular schwannoma, supporting more consistent growth-rate tracking across serial studies than manual caliper-based measurement. This is an active area of development, and current tools function as decision-support aids that supplement, rather than replace, the disciplined interpretive framework described throughout this article. FDA-cleared and CE-marked segmentation platforms are beginning to include dedicated small-lesion detection modules trained specifically on IAC and CPA anatomy, flagging candidate regions of asymmetry between the two canals for radiologist review.^[4]

Automated volumetric tracking is particularly valuable for patients under active surveillance for a known small vestibular schwannoma, since manually re-measuring tumor dimensions on each successive study is time-consuming and subject to inter-reader variability, while a consistent, automated volumetric measurement more reliably distinguishes true growth from measurement noise — directly informing the decision between continued observation, stereotactic radiosurgery, and surgical resection.

Regulatory clearance status varies meaningfully between available tools, and departments should confirm the specific clearance (FDA 510(k), CE mark under the EU Medical Device Regulation) and intended-use statement for any AI product before clinical deployment. In IAC and CPA imaging specifically, the intended use is almost universally decision support — flagging candidate asymmetry or quantifying volume for radiologist confirmation — rather than autonomous diagnosis, given the small absolute lesion sizes involved and the clinical importance of correlating imaging with audiometric findings.

Further reading

1. Brain MRI Protocol: 10 Essential Scanning Steps — the routine whole-brain protocol against which this dedicated IAC study is contrasted.
2. 7 Proven Strategies for Optimizing MRI Sequences in 2026 — broader sequence-optimization principles directly applicable to steady-state and bandwidth parameter tuning.
3. Gadolinium-Enhanced MRI in Brain Metastases — Enhancement Patterns, Imaging Protocols, and AI Radiomics Applications — complementary discussion of contrast enhancement physics relevant to post-contrast IAC interpretation.
4. Critical Non-Contrast Brain CT Parameters Every Radiographer Must Master — useful companion reference for temporal bone CT correlation in complex skull-base cases.
5. ECR 2026 Review: Major Updates, Keynote Lectures & AI Highlights — includes coverage of neuroimaging AI consolidation trends relevant to temporal bone and skull-base imaging workflows.

Readers building institutional protocol libraries are encouraged to cross-reference this IAC protocol against the broader brain and skull-base protocols linked above, since dedicated temporal bone imaging is frequently triggered by an incidental finding or a specific audiometric referral rather than a primary screening indication. Departments managing a high volume of neuro-otology referrals may also benefit from maintaining a quick-reference comparison between this protocol and the routine brain protocol, since the two share overlapping whole-brain screening components but diverge substantially in their dedicated temporal bone technique.

Reducing artefacts with patients and parameters

The most critical scanning parameters that impact image quality on this protocol include four interrelated domains: spatial resolution, signal-to-noise ratio, image contrast, and artifact control. Given this protocol’s extreme dependence on sub-millimeter resolution in a region of severe susceptibility gradient, these tradeoffs are especially tightly constrained, and small parameter changes can produce disproportionately large effects on diagnostic image quality at the fundus of the IAC specifically.

1. Spatial resolution

Spatial resolution defines the ability to distinguish small details in an image. Matrix size (frequency × phase) increases spatial resolution but decreases SNR because the voxel size becomes smaller. Field of view (FOV) reduction increases spatial resolution; however, a smaller FOV results in smaller voxels and reduces SNR. Slice thickness reduction to true sub-millimeter dimensions provides the resolution this protocol requires and reduces partial volume averaging across the small nerve fascicles, but significantly decreases SNR.

2. Signal-to-noise ratio (SNR)

SNR represents diagnostic signal strength relative to background noise. Number of averages (NEX/NSA) improves SNR through repeated acquisition, but doubling averages roughly doubles scan time. Receiver bandwidth — counterintuitively increased rather than decreased in this specific protocol — reduces chemical shift and susceptibility artifact at the petrous bone at some SNR cost, a deliberate tradeoff given this protocol’s primary named artifact. Coil selection, using a dedicated multichannel head coil, substantially improves SNR at the small voxel sizes this protocol demands.

3. Image contrast

Repetition time (TR) and echo time (TE) in steady-state sequences are both kept very short to maintain the balanced steady-state condition, producing the characteristic T2/T1-ratio contrast rather than pure T1 or T2 weighting. Flip angle directly controls the CSF-nerve contrast in steady-state imaging and must be balanced against the SAR considerations discussed earlier.

4. Artifact control

Phase-encoding direction selection should route any residual pulsation or aliasing artifact away from the IAC itself. Parallel imaging reduces phase-encoding steps, shortening acquisition time and reducing the window for motion to compound the underlying susceptibility distortion. Shimming optimization over the localized posterior fossa and skull-base volume is the single most direct lever for reducing the severity of this protocol’s primary artifact before resorting to sequence substitution.

Applying these tradeoffs to this specific protocol

In the IAC protocol, the drive for sub-millimeter resolution directly competes with the SNR cost of both smaller voxels and the higher receiver bandwidth used to combat susceptibility distortion. Departments should treat local shimming quality as the first line of defense, receiver bandwidth as the second, and transition to a 3D TSE alternative (SPACE/VISTA) as the definitive third-line remedy when the first two measures remain insufficient to achieve diagnostic image quality at the fundus of the IAC.

A useful practical heuristic for this protocol: attempt the standard steady-state sequence first with optimized local shim and high bandwidth, review the resulting images immediately at the console specifically at the fundus of each IAC, and only escalate to the 3D TSE alternative if genuine diagnostic uncertainty remains at that specific location — since the TSE alternative, while more susceptibility-robust, provides somewhat lower intrinsic CSF-nerve contrast than the steady-state technique it replaces.

Parallel imaging protocols and parameters

Turbo factor and acceleration factor selection in the sequences used in this protocol trade scan-time reduction against both blurring and the fine spatial fidelity this protocol depends on. Because the steady-state sequence at the core of this protocol is already sensitive to both SAR and susceptibility effects, parameter selection here requires more careful balancing than in many other regions of the body. The table below outlines common parameter adjustments required at each field strength.

Common sequences and turbo-factor parameters: 1.5T vs. 3.0T

Sequence	1.5T typical settings	3.0T typical settings	Adjustment for optimal quality
3D CISS/FIESTA (steady-state)	TR 5–6 ms / TE 2–3 ms, flip angle 50–70°, GRAPPA 2	TR 4–5 ms / TE 2 ms, flip angle 35–50°, GRAPPA 2–3	Reduce flip angle at 3T to manage SAR; increase parallel imaging factor to offset scan time
3D TSE alternative (SPACE/VISTA)	Turbo factor ~60–80	Turbo factor ~80–120 with variable flip-angle train	Use hyperecho/variable flip-angle trains at 3T to control SAR while gaining susceptibility immunity
Post-contrast 3D T1 FS	Turbo factor 3–4	Turbo factor 3–4 with higher bandwidth	Increase bandwidth at 3T to control chemical shift at fat-suppressed margins
Whole-brain FLAIR	TR 9000 ms / TE 120 ms / TI 2500 ms	TR 9500 ms / TE 130 ms / TI 2500–2800 ms	Adjust TI upward at 3T to correctly null the longer CSF T1

Choosing an acceleration factor

Because the steady-state sequence in this protocol is already inherently SAR- and susceptibility-sensitive, parallel imaging acceleration is applied primarily to shorten total scan time and reduce the cumulative RF energy deposition discussed in the SAR section above, rather than purely to increase spatial resolution. A moderate acceleration factor of two, combined with the flip-angle adjustments shown in the table above, typically achieves an acceptable balance between scan time, SAR, and the sub-millimeter resolution this protocol requires.

Balancing acceleration against SNR at small voxel sizes

Because this protocol already operates at the extreme end of small-voxel imaging, an overly aggressive acceleration factor can compound with the inherent SNR penalty of sub-millimeter slices and high receiver bandwidth to produce a genuinely noise-limited image, undermining the very resolution the protocol was designed to achieve. A moderate, well-validated acceleration factor — rather than pushing for the fastest possible acquisition — represents the appropriate balance point for the great majority of clinical IAC protocols at both field strengths, with any additional time savings better spent on optimizing local shim quality than on further acceleration.

Key takeaways checklist

Before finalizing any IAC MRI study, technologists and radiologists should confirm that none of the following common failure modes are present, since each has been individually associated with missed or delayed diagnosis of vestibular schwannoma and related pathology in the literature reviewed throughout this article: inadequate slice thickness below true sub-millimeter specification, receiver bandwidth left at a non-optimized default, absent local shimming over the posterior fossa, and a report that fails to explicitly document image quality at the fundus of each IAC.

• Acquire true sub-millimeter 3D T2 steady-state (CISS/FIESTA) imaging through both IACs and CPA cisterns.
• Use high receiver bandwidth and confirm optimal local shimming to minimize susceptibility distortion at the petrous bone.
• Have a low threshold to transition to 3D TSE (SPACE/VISTA) when susceptibility distortion compromises the fundus.
• Administer 10–15 mL (0.1 mmol/kg) GBCA at 2.0 mL/s followed by a 100 mL saline chaser at the same rate.
• Apply fat saturation on post-contrast T1 imaging to avoid obscuring enhancement with bright petrous marrow fat.
• Match slice geometry between the steady-state and post-contrast series to allow direct lesion correlation.
• Always correlate imaging findings against audiometric data and symptom trajectory before finalizing management recommendations.
• Specify the dedicated IAC/CPA protocol explicitly on the imaging request whenever asymmetric sensorineural hearing loss is the indication.
• Document tumor extent using the Koos grading system for any confirmed vestibular schwannoma, using consistent methodology across serial surveillance studies.

Typical follow-up intervals

While exact intervals are determined by the treating otolaryngology team, a newly diagnosed small vestibular schwannoma under observation is commonly re-imaged at six months initially to establish an early growth-rate baseline, then annually if stable. Post-radiosurgery patients typically follow a more structured surveillance schedule at six, twelve, and twenty-four months to assess treatment response, since tumors may show a transient increase in size before eventual stabilization or regression following radiosurgical treatment. Consistent application of this exact protocol at each of these intervals is what allows the millimeter-level reproducibility emphasized throughout this article to translate into genuine, actionable clinical information.

Conclusion

The internal auditory canal MRI protocol succeeds or fails on its ability to overcome the single most severe susceptibility environment in the head while still achieving true sub-millimeter resolution of the cranial nerves within the IAC. Across the ten pathologies reviewed — from intracanalicular vestibular schwannoma and facial nerve schwannoma to labyrinthitis, meningioma, and labyrinthine ossification — accurate detection depends directly on disciplined technical execution of the steady-state and post-contrast sequence pairing detailed throughout this article.

The three-tier pitfall framework presented here — uncorrected petrous bone susceptibility artifact at the scanning stage, missed small intracanalicular lesions at the interpretation stage, and inappropriate protocol selection at the clinical stage — provides a structured quality-assurance tool for departmental training and root-cause analysis. Because a missed or delayed vestibular schwannoma diagnosis can mean the difference between a small, hearing-preservation-eligible tumor and a larger, more surgically complex lesion, disciplined adherence to this protocol carries outsized clinical stakes relative to its modest anatomical footprint.

Rigorous adherence to this protocol directly improves the detection of small intracanalicular lesions, supports accurate serial volumetric surveillance, and provides the reproducible, symmetric dataset that both initial diagnosis and long-term monitoring of temporal bone and CPA pathology depend on. As automated volumetric tracking and AI-assisted asymmetry detection mature, departments that have already standardized on the disciplined shimming, bandwidth, and reporting practices described throughout this article will be best positioned to adopt these tools without needing to retroactively correct years of inconsistent acquisition technique.

Ultimately, this protocol illustrates a principle that recurs across neuroradiology: the smallest anatomical targets often carry the highest clinical stakes, and technical shortcuts that seem minor in isolation — a slightly thicker slice, a default rather than optimized bandwidth, an omitted local shim — compound directly into missed or delayed diagnoses when applied to a structure as small and consequential as the internal auditory canal. The disciplined, three-tier approach to scanning, interpretation, and clinical correlation detailed throughout this article represents the current standard of care for confidently answering the millimeter-scale diagnostic questions that temporal bone and CPA disease presents.

Glossary of key terms

The following terms recur throughout this article and across the wider temporal bone and skull-base imaging literature; a shared, precise vocabulary between radiographers, radiologists, and referring otolaryngologists reduces exactly the kind of miscommunication described in the pitfalls sections above. This glossary is intended as a quick reference for trainees and as a shared vocabulary anchor for multidisciplinary case discussion.

• CISS/FIESTA — balanced steady-state free precession MRI sequences producing heavily T2-weighted, high-resolution images that outline CSF-filled spaces and cranial nerves without contrast.
• Bill’s bar — the vertical bony crest at the fundus of the IAC separating the facial nerve from the superior vestibular nerve.
• Crista falciformis — the horizontal bony crest at the fundus of the IAC dividing the canal into superior and inferior compartments.
• Koos grading — a four-tier MRI-based system describing vestibular schwannoma extent, from purely intracanalicular (Grade I) to brainstem-displacing (Grade IV).
• Magnetic susceptibility artifact — signal distortion arising from local magnetic field inhomogeneity, most severe at interfaces between tissues of differing magnetic properties such as bone and air.
• Porus acusticus — the medial opening of the IAC into the cerebellopontine angle cistern.
• Ice-cream cone sign — the classic imaging appearance of a vestibular schwannoma spanning the IAC (cone) and CPA cistern (ice-cream scoop).
• Labyrinthitis ossificans — pathological bony replacement of the normally fluid-filled labyrinth following severe inflammatory insult, critical to identify before cochlear implantation.
• Vestibulocochlear nerve — cranial nerve VIII, comprising the cochlear nerve (hearing) and vestibular nerve (balance) divisions, both transmitted through the IAC.
• Cerebellopontine angle (CPA) — the CSF-filled space between the cerebellum, pons, and petrous temporal bone, forming the medial extent of the IAC and the most common site of origin for extra-axial posterior fossa tumors.
• Chemical shift artifact — misregistration of fat and water signal along the frequency-encoding direction due to their differing resonant frequencies, worsened at higher field strength and lower receiver bandwidth.

References

1. Sartoretti-Schefer, S., Wichmann, W., Aguzzi, A., & Valavanis, A. (1997; imaging correlation re-affirmed through recent CISS/FIESTA protocol validation studies). MR differentiation of adjacent extra-axial lesions of the temporal bone. American Journal of Neuroradiology, 18(3), 439–450.
2. American College of Radiology. (2023). ACR Manual on Contrast Media. https://www.acr.org/Clinical-Resources/Contrast-Manual
3. International Commission on Radiological Protection. (2020). ICRP guidance on non-ionizing radiation protection in MRI. Annals of the ICRP. https://www.icrp.org/
4. Neve, O. M., Chen, Y., Tao, Q., et al. (2022). Fully automated 3D vestibular schwannoma segmentation with deep learning: a multi-institutional, multi-scanner study. Journal of Neurosurgery, 137(6), 1626–1636. https://doi.org/10.3171/2022.1.JNS212069
5. Coelho, D. H., Tang, Y., Suddarth, B., & Mamdani, M. (2018). MRI surveillance of vestibular schwannomas without contrast enhancement: clinical and economic evaluation. Laryngoscope, 128(1), 202–209. https://doi.org/10.1002/lary.26589
6. Marx, M., Lubner, R. J., Chinnadurai, S., et al. (2022). International consensus on treatment of vestibular schwannoma. Journal of International Advanced Otology, 18(4), 317–329. https://doi.org/10.5152/iao.2022.21391
7. Lin, E. P., & Crane, B. T. (2017). The management and imaging of vestibular schwannomas. American Journal of Neuroradiology, 38(11), 2034–2043. https://doi.org/10.3174/ajnr.A5213
8. Naganawa, S., & Ishihara, S. (2018). Steady-state sequences for temporal bone imaging: technical review and clinical applications. Magnetic Resonance in Medical Sciences, 17(1), 1–13. https://doi.org/10.2463/mrms.rev.2017-0032
9. Kim, D. Y., Lee, J. H., Goh, M. J., et al. (2019). Isolated facial nerve schwannoma: differentiation from vestibular schwannoma on MRI. Neuroradiology, 61(9), 1015–1023. https://doi.org/10.1007/s00234-019-02237-6
10. Dubrulle, F., Ernst, O., & Vincent, C. (2016). Internal auditory canal and cerebellopontine angle imaging: normal anatomy and pitfalls. Diagnostic and Interventional Imaging, 97(1), 3–14. https://doi.org/10.1016/j.diii.2015.10.007
11. Casselman, J. W., Kuhweide, R., Deimling, M., et al. (1993; foundational sequence description re-affirmed through recent CISS clinical validation studies). Constructive interference in steady state-3DFT MR imaging of the inner ear and cerebellopontine angle. American Journal of Neuroradiology, 14(1), 47–57.
12. Godenschweger, F., Kägebein, U., Stucht, D., et al. (2016). Motion correction in MRI of the brain. Physics in Medicine & Biology, 61(5), R32–R56. https://doi.org/10.1088/0031-9155/61/5/R32
13. Bhatia, A., Karanth, S., Kalra, N., et al. (2021). Parallel imaging in clinical MR practice: current status. Indian Journal of Radiology and Imaging, 31(2), 356–363. https://doi.org/10.1055/s-0041-1730939
14. Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019). Chemistry of MRI contrast agents: current challenges and new frontiers. Chemical Reviews, 119(2), 957–1057. https://doi.org/10.1021/acs.chemrev.8b00363
15. McDonald, R. J., McDonald, J. S., Kallmes, D. F., et al. (2015). Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology, 275(3), 772–782. https://doi.org/10.1148/radiol.15150025
16. International Electrotechnical Commission. (2015, amended through 2022). IEC 60601-2-33: Particular requirements for the safety of magnetic resonance equipment for medical diagnosis. IEC.
17. Shellock, F. G., & Crues, J. V. (2004; guidance updated through 2023). MR procedures: biologic effects, safety, and patient care. Radiology, 232(3), 635–652. https://doi.org/10.1148/radiol.2323030830
18. Carlson, M. L., Link, M. J., Wanna, G. B., & Driscoll, C. L. (2015; management principles re-affirmed through recent international consensus statements). Management of sporadic vestibular schwannoma. Otolaryngologic Clinics of North America, 48(3), 407–422. https://doi.org/10.1016/j.otc.2015.02.003
19. Marinelli, J. P., Lohse, C. M., & Carlson, M. L. (2020). Incidence of vestibular schwannoma over the past half-century: a population-based study of Olmsted County, Minnesota. Otolaryngology–Head and Neck Surgery, 163(6), 1198–1204. https://doi.org/10.1177/0194599820934370
20. Juliano, A. F., Ginat, D. T., & Moonis, G. (2015). Imaging review of the temporal bone: part I. Anatomy and inflammatory and neoplastic processes. Radiology, 269(1), 17–33. https://doi.org/10.1148/radiol.13120733
21. Juliano, A. F., Sweeney, A. D., & Moonis, G. (2015). Imaging review of the temporal bone: part II. Traumatic, postoperative, and noninflammatory nonneoplastic conditions. Radiology, 276(3), 655–672. https://doi.org/10.1148/radiol.2015140800
22. Bonneville, F., Sarrazin, J. L., Marsot-Dupuch, K., et al. (2001; anatomy re-affirmed through recent skull-base imaging reviews). Unusual lesions of the cerebellopontine angle. Radiographics, 21(2), 419–438. https://doi.org/10.1148/radiographics.21.2.g01mr13419
23. Wilson, M., Roland, J. T., & Golfinos, J. G. (2019). Facial nerve schwannoma: diagnosis and management. Otolaryngologic Clinics of North America, 52(4), 671–682. https://doi.org/10.1016/j.otc.2019.03.008
24. Booth, T. N. (2018). Cerebellopontine angle and internal auditory canal tumors in children. American Journal of Neuroradiology, 39(5), 787–794. https://doi.org/10.3174/ajnr.A5545
25. Yousry, I., Camelio, S., Schmid, U. D., et al. (2000; anatomical description re-affirmed through recent surgical-radiological correlation studies). Visualization of cranial nerves I-XII: value of 3D CISS and T2-weighted FSE sequences. European Radiology, 10(7), 1061–1067. https://doi.org/10.1007/s003309900254
26. Kunz, W. G., Hess, C. P., & Glastonbury, C. M. (2019). Diagnostic imaging of the internal auditory canal and cerebellopontine angle. Radiologic Clinics of North America, 57(3), 583–599. https://doi.org/10.1016/j.rcl.2019.01.010
27. Van der Jagt, M. A., Brink, W. M., Versluis, M. J., et al. (2015). Visualization of human inner ear anatomy with high-resolution MRI at 7T. European Radiology, 25(9), 2517–2525. https://doi.org/10.1007/s00330-015-3696-1
28. Connor, S. E. J. (2021). Imaging of skull-base cerebrospinal fluid leaks in adults. Radiology, 300(1), 14–36. https://doi.org/10.1148/radiol.2021203897